3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y CAGR while E4C.DE stands at 42.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y OCF/share CAGR while E4C.DE is at 36.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y net income/share CAGR while E4C.DE is 3783.01%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-100.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y equity/share growth while E4C.DE is at 28.62%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-100.00%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Negative near-term dividend growth while E4C.DE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.57%
Firm’s AR is declining while E4C.DE shows 13.57%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
20.58%
Inventory growth of 20.58% while E4C.DE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
21.66%
Asset growth above 1.5x E4C.DE's 5.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-100.00%
We have a declining book value while E4C.DE shows 9.48%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
80.69%
We have some new debt while E4C.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.